Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-040273
Filing Date
2025-04-28
Accepted
2025-04-28 17:01:59
Documents
23
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A tm252577-4_def14a.htm   iXBRL DEF 14A 736544
6 GRAPHIC bc_24investmenttsr-4c.jpg GRAPHIC 59721
7 GRAPHIC bc_24netloss-4c.jpg GRAPHIC 63895
8 GRAPHIC bc_investment-4clr.jpg GRAPHIC 56378
9 GRAPHIC bc_netloss-4clr.jpg GRAPHIC 53757
10 GRAPHIC px_25armataproxy1pg1-bw.jpg GRAPHIC 253949
11 GRAPHIC px_25armataproxy1pg2-bw.jpg GRAPHIC 245287
12 GRAPHIC sg_robinckramer-bw.jpg GRAPHIC 8233
  Complete submission text file 0001104659-25-040273.txt   3546281

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA armp-20241231.xsd EX-101.SCH 10194
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE armp-20241231_def.xml EX-101.DEF 3764
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20241231_lab.xml EX-101.LAB 37345
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20241231_pre.xml EX-101.PRE 6139
25 EXTRACTED XBRL INSTANCE DOCUMENT tm252577-4_def14a_htm.xml XML 296583
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37544 | Film No.: 25881392
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)